Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up

Cardiology Journal

Volumn 21, Issue 4, 2014, Pages 384-391

  Lodziński, Piotr ^a   Kiliszek, Marek ^a   Koźluk, Edward ^a   Piatkowska, Agnieszka ^a   Balsam, Paweł ^a   Kochanowski, Janusz ^a   Scisło, Piotr ^a   Piatkowski, Radosław ^a   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Atrial fibrillation; Early AF recurrence; Late AF recurrence; Pulmonary vein isolation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ADULT; ADVERSE EFFECTS; AMBULATORY ELECTROCARDIOGRAPHY; ATRIAL FIBRILLATION; CATHETER ABLATION; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECTS; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; POLAND; PROCEDURES; PROSPECTIVE STUDY; PULMONARY VEIN; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLAND; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE; RISK FACTORS; SOTALOL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906840898     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2013.0144     Document Type: Article

References (16)

1. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001; 285: 2370-2375.
2. Camm AJ, Kirchhof P, Lip GY et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace, 2010; 12: 1360-1420.
3. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). The Am J Cardiol, 1994; 74: 236-241.
4. Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation: Developed with the special contribution of the European Heart Rhythm Association. Europace, 2012; 14: 1385-1413.
5. Bertaglia E, Stabile G, Senatore G et al. Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation. Pacing and clinical electrophysiology. PACE, 2005; 28: 366-371.
6. Cai L, Yin Y, Ling Z et al. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol, 2013; 164: 82-87.
7. O'Donnell D, Furniss SS, Dunuwille A, Bourke JP. Delayed cure despite early recurrence after pulmonary vein isolation for atrial fibrillation. Am J Cardiol, 2003; 91: 83-85.
8. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahe I, Bergmann JF. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: A systematic review of randomized controlled trials. Arch Internal Med, 2006; 166: 719-728.
9. Hohnloser SH, Singh BN. Proarrhythmia with class III antiarrhythmic drugs: Definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol, 1995; 6 (10 Part 2): 920-936.
10. Friedman PL, Stevenson WG. Proarrhythmia. Am J Cardiol, 1998; 82: 50N-58N.
11. Roux JF, Zado E, Callans DJ et al. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study). Circulation, 2009; 120: 1036-1040.
12. Leong-Sit P, Roux JF, Zado E et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): Six-month follow-up study. Circulation, 2011; 4: 11-14.
13. Joshi S, Choi AD, Kamath GS et al. Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: Findings from 3 months of continuous automatic ECG loop recordings. J Cardiovasc Electrophysiol, 2009; 20: 1089-1094.
14. Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation, 2005; 112: 307-313.
15. Weerasooriya R, Khairy P, Litalien J et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol, 2011; 57: 160-166.
16. Arya A, Hindricks G, Sommer P et al. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace, 2010; 12: 173-180.